Earnings Feed
Start Free
BIOJECT MEDICAL TECHNOLOGIES INC·4

Feb 1, 7:03 PM ET

Makar Ralph 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 1, 2010

Insider Transaction Report

Form 4
Period: 2010-01-30
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
Makar Ralph
CEO/President
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    2010-01-30+50,000→ 394,034 total
  • Exercise/Conversion

    Restricted Stock Unit

    2010-01-30−50,000→ 307,601 total
    From: 2010-01-30→ BJCT Common Stock (50,000 underlying)
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    86,916
Footnotes (4)
  • [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F3]No expiration date.
  • [F4]Includes Series F Preferred Stock 67.600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 83,334.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT